Please login to the form below

Not currently logged in

Excellence in Physicians/Healthcare Provider Support Programmes

Sponsored by

Back to Results


Improving Practice in Anticoagulation Care

By: Bayer

Summary of work

Thromboembolic conditions, like Atrial Fibrillation (AF), Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) cost the NHS hundreds of millions of pounds a year and lead to tens of thousands of hospital admissions. Traditional agents have challenges; constant INR monitoring, often out of therapeutic range and can interfere with food and drink. With the introduction of Novel Oral Anticoagulants (NOACs), it’s now much easier to treat these common and costly conditions to reduce days in hospital and ensure patients are adequately protected. Despite updates to NICE guidance advocating patient access to the NOACs, uptake has been slow.

Improving Practice in Anticoagulation Care is the foundation for Bayer’s medical education offering. It is made up of three core educational initiatives, INNOVATE, X-IMPACT and Mediconf all of which have significantly impacted the management of AF, DVT and PE, while enhancing patient outcomes.

As Bayer is a leader in this field, it was imperative that it communicates the priority updates and aim to increase the confidence in the use of NOACs among healthcare providers.

Improving Practice in Anticoagulation Care has reached over 2,000 healthcare providers and generated a proven shift in behaviour which has changed current practice, challenging and improving existing standards of care.

Judges' comments

The scale and sheer comprehensiveness of Bayer’s programme ensured that it really stood out, thanks to their willingness to take on a vast task.

Highly commended

Allergan Medical Institute - By: Allergan
With support from: inVentiv Health

Highly commended

ADHD in practice - By: Shire International GmbH
With support from: Hayward Medical Communications


Improving Practice in Anticoagulation Care - By: Bayer

Virtual Valve - By: Edwards Lifesciences
With support from: emotive

Key dates

Entry deadline 26 August 2021
Extended entry deadline 2 September 2021*
*additional fee applies
Judging Day 1 October 2021
Company of the Year Interviews 22 October 2021
PMEA Event 24 November 2021